Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
NCT02550847
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DEVICE:
The imaging biomarkers determined by MR-PET
Sponsor
National Taiwan University Hospital